BOK Financial’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $132K | Sell |
1,455
-67
| -4% | -$6.15K | ﹤0.01% | 727 |
|
|
2025
Q4 | $137K | Buy |
1,522
+60
| +4% | +$5.69K | ﹤0.01% | 733 |
|
|
2025
Q3 | $144K | Sell |
1,462
-118
| -7% | -$11.7K | ﹤0.01% | 731 |
|
|
2025
Q2 | $144K | Sell |
1,580
-489
| -24% | -$47.3K | ﹤0.01% | 730 |
|
|
2025
Q1 | $234K | Hold |
2,069
| – | – | ﹤0.01% | 683 |
|
|
2024
Q4 | $216K | Sell |
2,069
-165
| -7% | -$17.7K | ﹤0.01% | 691 |
|
|
2024
Q3 | $233K | Hold |
2,234
| – | – | ﹤0.01% | 685 |
|
|
2024
Q2 | $242K | Sell |
2,234
-21
| -0.9% | -$2.48K | ﹤0.01% | 738 |
|
|
2024
Q1 | $293K | Sell |
2,255
-251
| -10% | -$31.4K | 0.01% | 652 |
|
|
2023
Q4 | $305K | Buy |
2,506
+269
| +12% | +$30K | 0.01% | 609 |
|
|
2023
Q3 | $234K | Sell |
2,237
-96
| -4% | -$12.2K | 0.01% | 619 |
|
|
2023
Q2 | $340K | Sell |
2,333
-549
| -19% | -$74.6K | 0.01% | 596 |
|
|
2023
Q1 | $372K | Sell |
2,882
-3,913
| -58% | -$491K | 0.01% | 597 |
|
|
2022
Q4 | $866K | Buy |
6,795
+21
| +0.3% | +$2.44K | 0.02% | 552 |
|
|
2022
Q3 | $708K | Sell |
6,774
-544
| -7% | -$59.7K | 0.01% | 582 |
|
|
2022
Q2 | $769K | Buy |
7,318
+421
| +6% | +$49.9K | 0.01% | 586 |
|
|
2022
Q1 | $882K | Sell |
6,897
-27
| -0.4% | -$3.25K | 0.01% | 607 |
|
|
2021
Q4 | $854K | Buy |
6,924
+441
| +7% | +$57.7K | 0.01% | 622 |
|
|
2021
Q3 | $921K | Buy |
+6,483
| New | +$954K | 0.02% | 589 |
|
|
2021
Q1 | $862K | Buy |
5,544
+347
| +7% | +$53.8K | 0.02% | 585 |
|
|
2020
Q4 | $778K | Buy |
5,197
+427
| +9% | +$60.3K | 0.01% | 575 |
|
|
2020
Q3 | $631K | Sell |
4,770
-141
| -3% | -$18.4K | 0.01% | 569 |
|
|
2020
Q2 | $569K | Buy |
4,911
+13
| +0.3% | +$1.5K | 0.01% | 594 |
|
|
2020
Q1 | $481K | Buy |
4,898
+928
| +23% | +$122K | 0.01% | 587 |
|
|
2019
Q4 | $577K | Buy |
3,970
+77
| +2% | +$10.6K | 0.01% | 666 |
|
|
2019
Q3 | $519K | Buy |
3,893
+82
| +2% | +$10.6K | 0.01% | 668 |
|
|
2019
Q2 | $436K | Sell |
3,811
-30
| -0.8% | -$3.51K | 0.01% | 697 |
|
|
2019
Q1 | $476K | Sell |
3,841
-51
| -1% | -$5.8K | 0.01% | 682 |
|
|
2018
Q4 | $392K | Buy |
3,892
+63
| +2% | +$7.08K | 0.01% | 672 |
|
|
2018
Q3 | $489K | Sell |
3,829
-58
| -1% | -$6.9K | 0.01% | 686 |
|
|
2018
Q2 | $421K | Buy |
3,887
+304
| +8% | +$33.1K | 0.01% | 710 |
|
|
2018
Q1 | $379K | Buy |
3,583
+15
| +0.4% | +$1.74K | 0.01% | 710 |
|
|
2017
Q4 | $418K | Sell |
3,568
-8,546
| -71% | -$966K | 0.01% | 707 |
|
|
2017
Q3 | $1.38M | Sell |
12,114
-1,353
| -10% | -$156K | 0.04% | 416 |
|
|
2017
Q2 | $1.68M | Buy |
13,467
+8,629
| +178% | +$1.02M | 0.05% | 359 |
|
|
2017
Q1 | $573K | Sell |
4,838
-662
| -12% | -$75K | 0.02% | 627 |
|
|
2016
Q4 | $551K | Sell |
5,500
-15,347
| -74% | -$1.64M | 0.02% | 610 |
|
|
2016
Q3 | $2.63M | Buy |
20,847
+118
| +0.6% | +$14.6K | 0.09% | 266 |
|
|
2016
Q2 | $2.42M | Sell |
20,729
-6,183
| -23% | -$700K | 0.09% | 265 |
|
|
2016
Q1 | $2.79M | Buy |
26,912
+21,301
| +380% | +$2.06M | 0.1% | 236 |
|
|
2015
Q4 | $559K | Sell |
5,611
-344
| -6% | -$33.7K | 0.02% | 552 |
|
|
2015
Q3 | $543K | Buy |
5,955
+53
| +0.9% | +$5.31K | 0.02% | 556 |
|
|
2015
Q2 | $626K | Buy |
5,902
+57
| +1% | +$6.31K | 0.02% | 547 |
|
|
2015
Q1 | $667K | Buy |
+5,845
| New | +$667K | 0.02% | 507 |
|
|
2014
Q4 | – | Sell |
-5,155
| Closed | -$504K | – | 808 |
|
|
2014
Q3 | $504K | Sell |
5,155
-488
| -9% | -$48K | 0.02% | 574 |
|
|
2014
Q2 | $569K | Sell |
5,643
-620
| -10% | -$60.5K | 0.02% | 587 |
|
|
2014
Q1 | $575K | Buy |
6,263
+26
| +0.4% | +$2.4K | 0.02% | 586 |
|
|
2013
Q4 | $565K | Buy |
6,237
+287
| +5% | +$24.8K | 0.02% | 587 |
|
|
2013
Q3 | $475K | Buy |
5,950
+649
| +12% | +$51.1K | 0.02% | 589 |
|
|
2013
Q2 | $386K | Buy |
+5,301
| New | +$396K | 0.01% | 609 |
|
Other funds holding ZBH
VCM
VPM
BOK Financial's ZBH Position: Q1 2026 in Review
BOK Financial reduced its Zimmer Biomet (ZBH) stake by 4.4% in Q1 2026, selling an estimated $6.15K and leaving 1,455 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #727.
BOK Financial first reported a position in ZBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.79M in Q1 2016. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- BOK Financial held 1,455 shares of Zimmer Biomet worth $132K as of Q1 2026.
- BOK Financial sold 67 Zimmer Biomet shares in Q1 2026, an estimated $6.15K.
- Zimmer Biomet made up ﹤0.01% of BOK Financial's portfolio in Q1 2026, its #727 holding.
- BOK Financial first reported a position in Zimmer Biomet in Q2 2013 and has held it in 50 quarters since.
- BOK Financial's Zimmer Biomet position peaked at $2.79M in Q1 2016.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on BOK Financial's 13F filing for Q1 2026, filed 8 May 2026.